Room for improvement in UK radiology services
This article was originally published in Clinica
Executive Summary
The UK NHS could save over £20 million ($30 million) a year by eliminating unnecessary X-ray examinations, according to a UK health services watchdog. A report from the Audit Commission quotes 1990 figures which indicate up to 20% of X-rays contribute almost nothing to the clinical care of patients and may be merely a "technological placebo" offered by referring hospital doctors and GPs. The report, which calls for a reorganisation of UK diagnostic imaging departments, also highlights inequities in the availability of high-tech equipment and deficient monitoring by radiology departments into how their assets are used.
You may also be interested in...
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.